Free Trial

Boston Scientific (BSX) Stock Price, News & Analysis

Boston Scientific logo
$102.42 -1.44 (-1.38%)
Closing price 03:59 PM Eastern
Extended Trading
$103.47 +1.05 (+1.03%)
As of 05:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Boston Scientific Stock (NYSE:BSX)

Advanced

Key Stats

Today's Range
$102.34
$105.49
50-Day Range
$94.92
$108.15
52-Week Range
$80.64
$109.50
Volume
11.00 million shs
Average Volume
8.03 million shs
Market Capitalization
$151.75 billion
P/E Ratio
60.96
Dividend Yield
N/A
Price Target
$122.21
Consensus Rating
Buy

Company Overview

Boston Scientific Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
95th Percentile Overall Score

BSX MarketRank™: 

Boston Scientific scored higher than 95% of companies evaluated by MarketBeat, and ranked 61st out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Boston Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 23 buy ratings, 2 hold ratings, and no sell ratings.

  • Upside Potential

    Boston Scientific has a consensus price target of $122.21, representing about 18.4% upside from its current price of $103.25.

  • Amount of Analyst Coverage

    Boston Scientific has been the subject of 16 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Boston Scientific's stock forecast and price target.
  • Earnings Growth

    Earnings for Boston Scientific are expected to grow by 13.33% in the coming year, from $2.85 to $3.23 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Boston Scientific is 61.49, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 82.66.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Boston Scientific is 61.49, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.67.

  • Price to Earnings Growth Ratio

    Boston Scientific has a PEG Ratio of 2.40. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Boston Scientific has a P/B Ratio of 6.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.31% of the outstanding shares of Boston Scientific have been sold short.
  • Short Interest Ratio / Days to Cover

    Boston Scientific has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Boston Scientific has recently increased by 2.00%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Boston Scientific does not currently pay a dividend.

  • Dividend Growth

    Boston Scientific does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.31% of the outstanding shares of Boston Scientific have been sold short.
  • Short Interest Ratio / Days to Cover

    Boston Scientific has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Boston Scientific has recently increased by 2.00%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Boston Scientific has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 61 news articles for Boston Scientific this week, compared to 44 articles on an average week.
  • Search Interest

    118 people have searched for BSX on MarketBeat in the last 30 days. This is an increase of 93% compared to the previous 30 days.
  • MarketBeat Follows

    30 people have added Boston Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 329% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Boston Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $17,972,457.00 in company stock.

  • Percentage Held by Insiders

    Only 0.50% of the stock of Boston Scientific is held by insiders.

  • Percentage Held by Institutions

    89.07% of the stock of Boston Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Boston Scientific's insider trading history.
Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BSX Stock News Headlines

Death Cross Stock Chart Grim Reaper
Beware the Death Cross: 3 Stocks Triggering This Spooky Signal
The Death Cross is something you never want to see on a stock you own. Take caution with these three companies that recently were visited by this scary signal.
Healthcare Stock ticker
3 Healthcare Stocks Using AI to Drive Growth
AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation...
Arizona-made nanochips the new millionaire maker?
George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the last 40 years. Now he's stepping forward with an even bigger prediction about what's being built in the Arizona desert. He believes 3 little-known companies will explode when a bombshell announcement just days from now. Smart investors are already positioning themselves.tc pixel
See More Headlines

BSX Stock Analysis - Frequently Asked Questions

Boston Scientific's stock was trading at $89.32 at the start of the year. Since then, BSX stock has increased by 15.6% and is now trading at $103.2460.

Boston Scientific Corporation (NYSE:BSX) issued its quarterly earnings results on Wednesday, October, 22nd. The medical equipment provider reported $0.75 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.71 by $0.04. Boston Scientific's revenue was up 20.3% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of Boston Scientific: VertiFlex, BTG, Augmenix, Veniti, Claret Medical, Cryterion Medical, nVision Medical, and others.

Top institutional investors of Boston Scientific include Ninety One UK Ltd (0.36%), Voya Investment Management LLC (0.30%), Robeco Institutional Asset Management B.V. (0.21%) and Assenagon Asset Management S.A. (0.20%). Insiders that own company stock include Michael F Mahoney, Daniel J Brennan, Joseph Michael Fitzgerald, Vance R Brown, Jonathan Monson, Eric Francis Yves Thepaut, Wendy Carruthers, Jeffrey B Mirviss, Nelda J Connors, Arthur C Butcher, John Bradley Sorenson, Edward J Ludwig, Edward J Ludwig, Yoshiaki Fujimori and Charles J Dockendorff.
View institutional ownership trends
.

Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Boston Scientific investors own include BlackRock (BLK), Broadcom (AVGO), ServiceNow (NOW), UnitedHealth Group (UNH), The Goldman Sachs Group (GS), NVIDIA (NVDA) and Illinois Tool Works (ITW).

Company Calendar

Last Earnings
10/22/2025
Today
10/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:BSX
CIK
885725
Employees
53,000
Year Founded
1979

Price Target and Rating

High Price Target
$136.00
Low Price Target
$100.00
Potential Upside/Downside
+17.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
27 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.68
Trailing P/E Ratio
61.70
Forward P/E Ratio
36.37
P/E Growth
2.4
Net Income
$1.85 billion
Net Margins
13.55%
Pretax Margin
16.22%
Return on Equity
19.21%
Return on Assets
10.62%

Debt

Debt-to-Equity Ratio
0.49
Current Ratio
1.37
Quick Ratio
0.82

Sales & Book Value

Annual Sales
$16.75 billion
Price / Sales
9.17
Cash Flow
$3.79 per share
Price / Cash Flow
27.37
Book Value
$14.93 per share
Price / Book
6.94

Miscellaneous

Outstanding Shares
1,481,750,000
Free Float
1,474,343,000
Market Cap
$153.60 billion
Optionable
Optionable
Beta
0.61

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NYSE:BSX) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners